Tuberculosis Trials Consortium Study 31

2018-02-05T16:32:49Z (GMT) by Payam Nahid
Tuberculosis Trials Consortium Study 31<br>Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial - Payam Nahid<br><br>This presentation was delivered at the 2017 INTERTB symposium, held at St George’s, University of London. The full collection of outputs from the meeting are available from the link below.